Recent analysis by the consumer advocacy group Which? has unveiled significant discrepancies in the omega-3 supplement market, revealing that many products marketed as “high strength” contain surprisingly low levels of essential fatty acids. This raises questions about the value consumers receive for their money when purchasing these supplements, contradicting expectations based on labelling.
A Closer Look at Omega-3 Standards
The investigation assessed 24 different omega-3 supplements against the guidelines established by the Scientific Advisory Committee on Nutrition (SACN), which recommends an average daily intake of 450mg of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The study set a benchmark of 1,000mg of combined EPA and DHA for products labelled as “high strength,” based on research indicating health benefits tied to these levels.
However, the findings were concerning. Several products, while marketed as high-strength, contained less EPA and DHA than the suggested daily intake. For instance, brands such as Superdrug, Morrisons, and Sainsbury’s offered omega-3 supplements that provided only 250mg of the active ingredients, despite their claims of high potency.
Price vs. Potency: A Costly Misunderstanding
The analysis revealed a stark contrast in pricing versus nutritional content. Sainsbury’s charged 14p per dose for its supplement containing only 250mg of EPA and DHA, a price double that of similar products at Asda and Tesco, which sold nutritionally equivalent versions for just 7p per dose. Similarly, Holland & Barrett’s High Strength Omega 3 Fish Oil, marketed as containing 1,500mg, only offered 375mg of EPA and DHA, at a cost of 27p per dose.
These findings suggest that consumers may be paying a premium for products that do not deliver on their health promises. Notably, some brands, such as Nutravita, Weightworld, and Zipvit, provided over 1,000mg of EPA and DHA for less than 20p per dose, highlighting the potential for consumers to access superior value elsewhere.
Labelling Practices Under Scrutiny
One of the key issues identified in the report was the labelling tactics employed by manufacturers. Many supplements prominently display the total quantity of fish oil per capsule on the front packaging, while the actual amounts of the beneficial EPA and DHA are often relegated to smaller print on the back. Which? has urged consumers to scrutinise labels carefully, advocating for a focus on the combined EPA and DHA content rather than relying on the more ambiguous front-of-pack claims.
Nutritionist Shefalee Loth from Which? commented on the implications of these findings, stating, “Our research shows cheaper alternatives can often provide just as much – or even more – nutritional value while offering far better value for money, so it’s worth checking the back of the pack rather than relying on front-of-pack claims.”
Retailer Responses and Compliance
In response to the findings, representatives from the retailers defended their labelling practices, asserting compliance with the Nutrition and Health Claims Regulation (EC No. 1924/2006). Superdrug noted that its product contains the requisite amount of EPA and DHA to justify its “high strength” label. Similarly, Sainsbury’s and Morrisons confirmed their adherence to regulatory standards, while Holland & Barrett clarified that there is no universally accepted definition of what constitutes a “high strength” omega-3 supplement.
Holland & Barrett further explained that their use of the term is intended to assist customers in navigating their product range, rather than conforming to an externally defined strength standard.
Why it Matters
The implications of this study extend beyond individual consumer choices; they highlight a broader issue within the supplement industry regarding transparency and consumer trust. As dietary supplements continue to gain popularity, ensuring that consumers receive accurate information about the products they purchase becomes increasingly critical. Misleading claims not only undermine consumer confidence but can also detract from the potential health benefits that omega-3 supplements offer. Ultimately, this investigation serves as a clarion call for more stringent regulation and clearer labelling practices, enabling consumers to make informed decisions that genuinely support their health and wellbeing.